Recombinant human serum albumin (rHSA)
Recombinant human serum albumin (rHSA) replaces plasma-derived HSA (pHSA) — constrained by donor blood supply and viral-contamination risk since the 1940s — with the first FDA/EMA/PMDA-approved rice-derived rHSA for injection. The global rHSA market was $166M.
Procurement category: fermentation & culture equipment. Bioecon selects suppliers and organises supply in this category to the customer's brief. Catalogue-level entry: the specific manufacturer, configuration and specification are determined at the enquiry stage. Price — on request.
| Category slug | upstream |
|---|---|
| Cluster | specialty-fine-chem |
| Article | recombinant-human-serum-albumin |
| Identifier | bio.eqp.recombinant-human-serum-albumin.upstream |
| NAICS | 333241 |
| Technique | Incubation & culture |
Every item is a procurement category, not a named manufacturer's product. Bioecon is a single seller and holds no stock: supplier selection, configuration and specification are settled at enquiry, and the price is by quote.